- ¥7bn
- ¥3bn
- ¥10bn
- 59
- 57
- 55
- 61
Annual income statement for Linical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 10,279 | 11,555 | 12,517 | 12,308 | 10,437 |
Cost of Revenue | |||||
Gross Profit | 2,768 | 3,612 | 4,162 | 3,778 | 2,376 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 10,053 | 10,609 | 11,183 | 11,724 | 11,033 |
Operating Profit | 226 | 946 | 1,334 | 583 | -596 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 359 | 1,032 | 1,379 | 660 | -513 |
Provision for Income Taxes | |||||
Net Income After Taxes | 540 | 790 | 1,004 | 338 | -539 |
Net Income Before Extraordinary Items | |||||
Net Income | 540 | 790 | 1,004 | 338 | -539 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 540 | 790 | 1,004 | 338 | -539 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 40.5 | 51.8 | 56.1 | 33.6 | -7.21 |
Dividends per Share |